Navigation Links
ITRA Global Report Makes the Case That Bio Tech Companies Should Consider Tucson, Arizona for Relocation or Expansion
Date:11/27/2013

Tucson, Arizona (PRWEB) November 27, 2013

Tucson, Arizona should be on any bioscience or biotechnology company’s short list for relocation or expansion, according to a white paper issued by ITRA Global affiliate Commercial Real Estate Group of Tucson LLC.

The nine-page report, “The Bio Industry in Tucson, Arizona,” points out that several bioscience companies already thrive in the region, including Ventana Medical Systems, Sanofi and SynCardia Systems. It also mentions that Accelerate Diagnostics moved from Denver to Tucson in 2012.

“I was impressed from my first contacts with Pima County, the Tucson mayor’s office, the state of Arizona and the Tucson Regional Economic Opportunities Office,” Accelerate President and CEO, Lawrence Mehren, is quoted as saying in the white paper. “We could tell this was a place that valued our businesses and wanted to help.”

“Proximity to large private enterprises in bioscience is only one of the reasons Tucson is a rising biotechnology star,” says Michael Coretz, principal of Commercial Real Estate Group of Tucson / ITRA Global. “Our city also boasts available venture capital, an encouraging spirit of entrepreneurship and a strong research community, including the University of Arizona’s Bio5 Institute.”

The availability of federal and state government funding and a highly skilled workforce are other reasons Tucson, the hub of Southern Arizona, should get prime consideration by biotechnology and bioscience firms, the report says.

Commercial Real Estate of Tucson is the Tucson Affiliate of ITRA Global and Michael Coretz is a site selection expert with indepth knowledge of biotech companies for local, regional and national clients. Specialized real estate needs for this industry are addressed in the white paper, which is available on the CREG of Tucson website.

ITRA Global is an organization of commercial real estate firms specializing in the representation of tenants and buyers of office, industrial, and retail facilities. It is one of the largest commercial real estate organizations devoted to representing corporate tenants and buyers. With coverage in major markets around the world, ITRA Global consists of seasoned professionals with an average of twenty years’ experience and is differentiated by its focus on advocacy for the corporate tenant and buyer. Clients benefit by having an experienced professional as their trusted advisor -- conflict-free representation with total objectivity.

For more information about the white paper, contact Michael Coretz by telephone at +1.520.299.3400 or by email, michael(at)cretucson.com. For more information about ITRA Global, you may contact the Executive Director of the organization, Beth Wade at +1.706.654.3201.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11374985.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
Breaking Biology News(10 mins):